So you think proper dosage is a big issue in ph 3 clinical trials? I don't think so. I'm no great expert but I think that ph 3 trials are assumed to be done using optimal doses.
Double dosing? Interesting—Could you please provide the source for that assertion? I am very curious to read the document where you got that peculiar detail from. Thanks!